Walgreens Shares Drop Amid Opioid Lawsuit by DOJ
Justice Department Files Opioid Crisis Lawsuit Against Walgreens
Walgreens Boots Alliance shares fell sharply after the Justice Department filed a lawsuit over alleged opioid-related misconduct.
The DOJ accuses Walgreens of filling prescriptions lacking legitimate medical purpose. This includes excessive quantities and early refills of opioids.
Stock Declines Following Lawsuit
Walgreens’ stock dropped 9% to $11.39 after Friday’s market close. Over the past year, shares have declined 43%.
The lawsuit adds to existing challenges for the pharmacy chain amid ongoing scrutiny over its role in the opioid crisis.
Walgreens Responds to Allegations
Walgreens stated that it stands behind its pharmacists. The company reaffirmed its commitment to responsible prescription practices.
Previous Settlements in the Opioid Crisis
Walgreens and competitor CVS have paid hundreds of millions in settlements for similar allegations in the past.
This latest lawsuit underscores ongoing accountability efforts related to the opioid epidemic.
